Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1116305.RALhrvOeMdktehqrLx3Moi5NfUPsvsfKYKJBZOV_yVEBY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1116305.RALhrvOeMdktehqrLx3Moi5NfUPsvsfKYKJBZOV_yVEBY130_assertion type Assertion NP1116305.RALhrvOeMdktehqrLx3Moi5NfUPsvsfKYKJBZOV_yVEBY130_head.
- NP1116305.RALhrvOeMdktehqrLx3Moi5NfUPsvsfKYKJBZOV_yVEBY130_assertion description "[High BCL2 levels have been detected in most human lymphoid malignancies, not limited to follicular lymphoma (where the role of BCL2 overexpression is driven by the t[14;18] translocation) but also B-cell chronic lymphocytic leukemia (CLL) and multiple myeloma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1116305.RALhrvOeMdktehqrLx3Moi5NfUPsvsfKYKJBZOV_yVEBY130_provenance.
- NP1116305.RALhrvOeMdktehqrLx3Moi5NfUPsvsfKYKJBZOV_yVEBY130_assertion evidence source_evidence_literature NP1116305.RALhrvOeMdktehqrLx3Moi5NfUPsvsfKYKJBZOV_yVEBY130_provenance.
- NP1116305.RALhrvOeMdktehqrLx3Moi5NfUPsvsfKYKJBZOV_yVEBY130_assertion SIO_000772 24095849 NP1116305.RALhrvOeMdktehqrLx3Moi5NfUPsvsfKYKJBZOV_yVEBY130_provenance.
- NP1116305.RALhrvOeMdktehqrLx3Moi5NfUPsvsfKYKJBZOV_yVEBY130_assertion wasDerivedFrom befree-2016 NP1116305.RALhrvOeMdktehqrLx3Moi5NfUPsvsfKYKJBZOV_yVEBY130_provenance.
- NP1116305.RALhrvOeMdktehqrLx3Moi5NfUPsvsfKYKJBZOV_yVEBY130_assertion wasGeneratedBy ECO_0000203 NP1116305.RALhrvOeMdktehqrLx3Moi5NfUPsvsfKYKJBZOV_yVEBY130_provenance.